Executive Director, US Portfolio Analytics
Revolution Medicines · Redwood City, California, United States
- Senior
- Full-time
- $211,000 – $264,000
- Posted 2026-09-24
- Confirmed live on 25 September 2026
Job description
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting directly to the Vice President, US Analytics & Insights, the Executive Director, US Portfolio Analytics will lead the portfolio-wide analytics capabilities that enable data-driven commercial decision-making across Revolution Medicines’ US business. This leader will be accountable for Field Analytics, Market Access Analytics, Data Strategy & Governance, Omnichannel Analytics, and Dashboards, ensuring scalable, integrated capabilities that support launch readiness, commercialization, and performance management across the portfolio.
This role will serve as a strategic thought partner to US Commercial leadership and franchise Analytics & Insights leaders, translating business priorities into an integrated analytics roadmap and establishing consistent standards, methodologies, data definitions, and decision support across brands and functions. The Executive Director will operate as a player/coach—personally engaging in high-priority analyses and capability design while building, leading, and developing a high-performing team.
Candidates should bring deep biopharma commercial analytics expertise, strong business and technical acumen, and a track record of building scalable analytics capabilities in an agile, fast-growing organization. This position is based out of our headquarters in Redwood City, CA.
Specifically, you will be responsible for:
•
Portfolio analytics leadership. Serve as the senior leader for US Portfolio Analytics, defining the vision, operating model, capability roadmap, resourcing requirements, and prioritization approach for analytics across the US portfolio.
•
Field Analytics. Lead the Field Analytics team and oversee field analytics strategy and execution, including healthcare professional (HCP) and account segmentation and targeting, field-force sizing and alignment and analytics, and field performance measurement. In collaboration with Field leadership and Field Operations, establish national, regional, territory, and account-level performance frameworks, KPIs, dashboards, and analytics that identify leading indicators, execution gaps, growth opportunities, and actions for field leadership. Partner closely with Field Operations to provide analytics supporting field-force design and optimization, productivity, resource allocation, and incentive compensation.
•
Market Access Analytics. Lead the Market Access Analytics team supporting payer coverage and access, reimbursement, channel and account performance, patient access, patient-services hub and specialty-pharmacy performance, payer pull-through, and evolving policy dynamics; provide analytical support for pricing, contracting, and gross to net assumptions in partnership with Market Access, Finance, and Forecasting.
•
Data Strategy and Governance. Own the commercial analytics data strategy and roadmap across internal and external data assets; lead the data team in evaluating and onboarding new data sources and vendors, and contributing to the business requirements for data warehouse, customer relationship management (CRM), master data, business intelligence, and analytics platforms in close partnership with the Information Systems team. Lead the collaborative cross-functional Data Strategy Working Group optimize RevMed’s data strategy through transparent communication, business case reviews and cross-functional synergies. Manage the central repository of data providers.
•
Omnichannel Analytics. Lead the Omnichannel Analytics Team which conducts the measurement and optimization for HCP and patient omnichannel engagement across multiple customer engagement channels, including customer journey analytics, channel effectiveness, attribution and marketing-mix approaches, test-and-learn programs, and advanced personalization and next-best-action use cases.
•
Reporting & business intelligence. Partnering with the brand A&I teams to define the portfolio key performance indicators (KPIs) and representation on dashboards; oversee recurring performance reporting, executive dashboards and self-service business intelligence to create a consistent, decision-ready view of business performance and a single source of truth.
•
Prepare for the interview
Nothing collected for this employer yet. The Blind 75 is what technical screens draw from; practise it here, with a coach, in Java or Python.
More at Revolution Medicines
- Senior Administrative Assistant II, Commercialization · Redwood City, California, United States
- Senior Research Associate, DMPK · Redwood City, California, United States
- Director, Drug Product · Redwood City, California, United States
- Associate Director, Payroll, Europe · Basel, Switzerland
- Contract Administrator III · Redwood City, California, United States
- Senior Administration Assistant · Redwood City, California, United States
- Principal Product Manager, Chemistry · Redwood City, California, United States
- Senior Product Manager Oncology, France · Paris, France